scispace - formally typeset
C

Chien-Feng Li

Researcher at National Health Research Institutes

Publications -  218
Citations -  4509

Chien-Feng Li is an academic researcher from National Health Research Institutes. The author has contributed to research in topics: Cancer & Nasopharyngeal carcinoma. The author has an hindex of 34, co-authored 191 publications receiving 3636 citations. Previous affiliations of Chien-Feng Li include Chung Hwa University of Medical Technology & Kaohsiung Medical University.

Papers
More filters
Journal ArticleDOI

Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.

TL;DR: Despite Ki-67 LI being an independent prognosticator, simultaneous detection of Mcm2 is recommended as a prognostic adjunct of GISTs, given its better sensitivity and stepwise escalation with increasing risk levels.
Journal ArticleDOI

Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers

TL;DR: The identification of PTX3 provided a new insight in the interaction between host and tumor and the RI37 peptide showed a great opportunity to largely reduce the risk of invasion and metastasis of cancer and drug-resistant cancers.
Journal ArticleDOI

ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer

TL;DR: Evidence is provided that ZBRK1 acts to inhibit metastasis of cervical carcinoma, perhaps by modulating MMP9 expression, which is known to be an important driver of invasion and metastasis.
Journal ArticleDOI

Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: a comparative histological, immunohistochemical and molecular study of 36 cases.

TL;DR: Solitary fibrous tumour harbours recurrent inv12(q13q13)‐derived NAB2–STAT6 fusions, resulting in STAT6 nuclear expression, and its clinicopathological, immunohistochemical, and genetic features are reported.
Journal Article

CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder

TL;DR: In this paper, the cell division cycle associated 5 (CDCA5) was identified as the most significantly upregulated gene among those associated with G1-S transition of the mitotic cell cycle.